SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-003202
Filing Date
2021-01-20
Accepted
2021-01-20 15:43:56
Documents
5
Period of Report
2021-01-20
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea133653-8k_inmed.htm 8-K 19163
2 LETTER, DATED JANUARY 20, 2021 ea133653ex99-1_inmed.htm EX-99.1 22345
3 GRAPHIC image_001.jpg GRAPHIC 53573
4 GRAPHIC image_002.jpg GRAPHIC 25738
5 GRAPHIC image_003.jpg GRAPHIC 8070
  Complete submission text file 0001213900-21-003202.txt   163320
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 21538702
SIC: 2834 Pharmaceutical Preparations